iPSC-derived cardiac organoids for drug cardiotoxicity evaluation and efficacy prediction in myocardial infarction and cardiac hypertrophy models
Chenjiao Hou, Qi Zhang, Ziyi Zhang, Xiaoye Lin, Haopeng Pan, Feng Wang, Jinfang Lou, Lei Miao, Bofan Song, Jianghai Wang, Huifang Zhao · 2026
Read iPSC-derived cardiac organoids for drug cardiotoxicity evaluation and efficacy prediction in myocardial infarction and cardiac hypertrophy models by Chenjiao Hou, Qi Zhang, Ziyi Zhang, Xiaoye Lin, Haopeng Pan, Feng Wang, Jinfang Lou, Lei Miao, Bofan Song, Jianghai Wang, Huifang Zhao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13520321.txt.
Description
Chenjiao Hou and colleagues describe in 2026 miniature heart tissues grown from reprogrammed human stem cells, used to test drug harm and benefit without animal hearts. The tissues beat on their own and copy key features of real heart muscle.
Known heart-damaging and heart-protecting drugs were applied to the tissues, including a cancer drug noted for heart injury and a birth-defect drug used as a harm check. Beating, survival signals and injury models for heart attack and thickened heart muscle were tracked. Responses matched expected drug effects, supporting the tissues as a screening platform. Further validation would be needed before routine drug decisions rely on them.
Catalog record
| CREATOR | Chenjiao Hou, Qi Zhang, Ziyi Zhang, Xiaoye Lin, Haopeng Pan, Feng Wang, Jinfang Lou, Lei Miao, Bofan Song, Jianghai Wang, Huifang Zhao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 64796 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |